About this paper
The pharmaceutical industry is facing trends that will continue to erode profitability if the sales and marketing model does not change. Prevailing market forces, regulatory constraints and the scrutiny of senior management make it more critical than ever to show results—fast. But how do you determine which actions will most effectively build brand equity, accelerate the path from product launch to peak sales, maintain physician loyalty and contribute to the overall company mission? In this white paper, industry leaders weigh in on how pharmaceutical companies can exploit predictive analytics to improve their commercial programs.
SAS is the leader in business analytics software and services, and the largest independent vendor in the business intelligence market. Through innovative solutions, SAS helps customers at more than 80,000 sites improve performance and deliver value by making better decisions faster. Since 1976 SAS has been giving customers around the world The Power to Know® .